Skip to content
healthcare.dev
Get a free key

TYSABRI

NDC 64406-008, natalizumab, injection, from Biogen Inc..

Product NDC
64406-008
Status
Listed
Labeler
Biogen Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125104
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64406-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NATALIZUMAB300 mg/15mL

Pharmacologic classes

Integrin Receptor Antagonist [EPC]; Integrin Receptor Antagonists [MoA]

Package NDCNDC-11Package
64406-008-01644060008011 VIAL, SINGLE-USE in 1 CARTON (64406-008-01) / 15 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c5fdde91-1989-4dd2-9129-4f3323ea2962

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=64406-008

Use it

Look up 64406-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64406-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64406-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.